| miRNA | gene name | experiments | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| hsa-miR-200b-3p | PTPN12 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZEB2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BAP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZEB1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RERE |
|
||||||||||||||||||
| hsa-miR-200b-3p | EP300 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ETS1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | GATA4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | FN1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | WASF3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZFPM2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | MATR3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RNF2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BMI1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | E2F3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | VEGFA |
|
||||||||||||||||||
| hsa-miR-200b-3p | FLT1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | KDR |
|
||||||||||||||||||
| hsa-miR-200b-3p | RND3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CCNE2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BCL2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | XIAP |
|
||||||||||||||||||
| hsa-miR-200b-3p | SMAD2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CREB1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | KLHL20 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ELMO2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PTPRD |
|
||||||||||||||||||
| hsa-miR-200b-3p | ERBIN |
|
||||||||||||||||||
| hsa-miR-200b-3p | WDR37 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TCF7L1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | VAC14 |
|
||||||||||||||||||
| hsa-miR-200b-3p | HOXB5 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RIN2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RASSF2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | KLF11 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SEPT7 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SHC1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SUPV3L1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | MYB |
|
||||||||||||||||||
| hsa-miR-200b-3p | QRSL1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SUZ12 |
|
||||||||||||||||||
| hsa-miR-200b-3p | WNT1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | DNMT3A |
|
||||||||||||||||||
| hsa-miR-200b-3p | DNMT3B |
|
||||||||||||||||||
| hsa-miR-200b-3p | SP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | MSN |
|
||||||||||||||||||
| hsa-miR-200b-3p | DNMT1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | EZH2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | HFE |
|
||||||||||||||||||
| hsa-miR-200b-3p | DLC1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | HNRNPA3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | FERMT2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RAB21 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RAB3B |
|
||||||||||||||||||
| hsa-miR-200b-3p | RAB18 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RAB23 |
|
||||||||||||||||||
| hsa-miR-200b-3p | OXR1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | RASSF8 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PMAIP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | UHRF1BP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZFHX4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ACSL4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SHCBP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CAB39 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NRBP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ATP5G3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZMAT3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | N4BP2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | QKI |
|
||||||||||||||||||
| hsa-miR-200b-3p | ANKRD33B |
|
||||||||||||||||||
| hsa-miR-200b-3p | DNAJB6 |
|
||||||||||||||||||
| hsa-miR-200b-3p | DDIT4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | KLHL42 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PARD6B |
|
||||||||||||||||||
| hsa-miR-200b-3p | DNAJB9 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SHOC2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NUFIP2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NOTCH1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BTC |
|
||||||||||||||||||
| hsa-miR-200b-3p | CDKN1B |
|
||||||||||||||||||
| hsa-miR-200b-3p | LOX |
|
||||||||||||||||||
| hsa-miR-200b-3p | PHLPP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SEC23A |
|
||||||||||||||||||
| hsa-miR-200b-3p | ROCK2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PIN1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | DDX53 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PHF14 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CDC14B |
|
||||||||||||||||||
| hsa-miR-200b-3p | ZNF621 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CACNG8 |
|
||||||||||||||||||
| hsa-miR-200b-3p | FKBP5 |
|
||||||||||||||||||
| hsa-miR-200b-3p | M6PR |
|
||||||||||||||||||
| hsa-miR-200b-3p | KIF13A |
|
||||||||||||||||||
| hsa-miR-200b-3p | DENND5B |
|
||||||||||||||||||
| hsa-miR-200b-3p | MALT1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CYP1A1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SERPINH1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TJAP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TPD52L1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CASP2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | AVPR1A |
|
||||||||||||||||||
| hsa-miR-200b-3p | GPX8 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ABI2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CLEC2D |
|
||||||||||||||||||
| hsa-miR-200b-3p | UBE2D1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TP53INP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ELOC |
|
||||||||||||||||||
| hsa-miR-200b-3p | TBK1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PRRG4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PLCG1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NCOA2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | KRAS |
|
||||||||||||||||||
| hsa-miR-200b-3p | JUN |
|
||||||||||||||||||
| hsa-miR-200b-3p | CELF1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CCNT2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BAG4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TUBB2A |
|
||||||||||||||||||
| hsa-miR-200b-3p | TCF7L2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | GPATCH8 |
|
||||||||||||||||||
| hsa-miR-200b-3p | LMNB1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | C6orf47 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TRIM56 |
|
||||||||||||||||||
| hsa-miR-200b-3p | MAPK7 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CLPB |
|
||||||||||||||||||
| hsa-miR-200b-3p | TXNDC16 |
|
||||||||||||||||||
| hsa-miR-200b-3p | UNC119B |
|
||||||||||||||||||
| hsa-miR-200b-3p | TMEM119 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TAF1D |
|
||||||||||||||||||
| hsa-miR-200b-3p | PAK2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NLGN4X |
|
||||||||||||||||||
| hsa-miR-200b-3p | ERMP1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PDPK1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CAMSAP2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | GATA6 |
|
||||||||||||||||||
| hsa-miR-200b-3p | FRS2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CRLF3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | CDCA4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | YEATS4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | MLLT10 |
|
||||||||||||||||||
| hsa-miR-200b-3p | BBX |
|
||||||||||||||||||
| hsa-miR-200b-3p | ARPC3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PSD3 |
|
||||||||||||||||||
| hsa-miR-200b-3p | ABT1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | PPM1H |
|
||||||||||||||||||
| hsa-miR-200b-3p | INO80D |
|
||||||||||||||||||
| hsa-miR-200b-3p | IGF2 |
|
||||||||||||||||||
| hsa-miR-200b-3p | FAM216B |
|
||||||||||||||||||
| hsa-miR-200b-3p | PTPN4 |
|
||||||||||||||||||
| hsa-miR-200b-3p | TMEM70 |
|
||||||||||||||||||
| hsa-miR-200b-3p | STX16 |
|
||||||||||||||||||
| hsa-miR-200b-3p | SEC24A |
|
||||||||||||||||||
| hsa-miR-200b-3p | MTDH |
|
||||||||||||||||||
| hsa-miR-200b-3p | IRS1 |
|
||||||||||||||||||
| hsa-miR-200b-3p | NGRN |
|
||||||||||||||||||
| hsa-miR-200b-3p | PABPC1 |
|
| authors | journal | year | Pubmed link | title | |
|---|---|---|---|---|---|
| 1 | Meng et al. | Gastroenterology | 2006 | 16762633 | Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. |
| 2 | Xiong et al. | Am. J. Physiol. Renal Physiol. | 2012 | 22012804 | The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. |
| 3 | Kurashige et al. | Carcinogenesis | 2015 | 25411357 | Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. |
| 4 | Bendoraite et al. | Gynecol. Oncol. | 2010 | 19854497 | Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. |
| 5 | Oba et al. | PLoS ONE | 2010 | 21049046 | miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. |
| 6 | Fang et al. | Exp. Mol. Pathol. | 2014 | 24769353 | Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer. |
| 7 | Korpal et al. | J. Biol. Chem. | 2008 | 18411277 | The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. |
| 8 | et al. | None | 21038317 | ||
| 9 | Ahmad et al. | Cancer Res. | 2011 | 21389093 | Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. |
| 10 | Chen et al. | Int. J. Mol. Med. | 2012 | 22294131 | miR-200b is involved in intestinal fibrosis of Crohn's disease. |
| 11 | Tang et al. | Am. J. Physiol. Renal Physiol. | 2013 | 23408168 | MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells. |
| 12 | Minn et al. | Int. J. Oncol. | 2014 | 25270520 | MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma. |
| 13 | Gregory et al. | Nat. Cell Biol. | 2008 | 18376396 | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
| 14 | Tryndyak et al. | Int. J. Cancer | 2010 | 19839049 | E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. |
| 15 | Bracken et al. | Cancer Res. | 2008 | 18829540 | A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. |
| 16 | Kurashige et al. | Ann. Surg. Oncol. | 2012 | 22311119 | MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. |
| 17 | Wang et al. | Am. J. Hypertens. | 2010 | 19910931 | Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. |
| 18 | Iorio et al. | Cancer Res. | 2007 | 17875710 | MicroRNA signatures in human ovarian cancer. |
| 19 | Hyun et al. | Cell | 2009 | 20005803 | Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. |
| 20 | Davalos et al. | Oncogene | 2012 | 21874049 | Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. |
| 21 | Reddy et al. | Arterioscler. Thromb. Vasc. Biol. | 2012 | 22247255 | Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. |
| 22 | Guo et al. | Oncogene | 2013 | 23318420 | Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. |
| 23 | Karres et al. | Cell | 2007 | 17923093 | The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. |
| 24 | Mees et al. | Int. J. Cancer | 2010 | 19569050 | EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. |
| 25 | Chan et al. | J. Biol. Chem. | 2011 | 21081489 | miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. |
| 26 | Yao et al. | RNA Biol | 2013 | 23558708 | miR-200b targets GATA-4 during cell growth and differentiation. |
| 27 | Sossey-Alaoui et al. | J. Biol. Chem. | 2009 | 19801681 | The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. |
| 28 | Xiao et al. | Cell. Signal. | 2014 | 24412919 | Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling. |
| 29 | Bimpaki et al. | Clin. Endocrinol. (Oxf) | 2010 | 19849700 | MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis. |
| 30 | Cao et al. | Cancer Cell | 2011 | 21840484 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. |
| 31 | Yu et al. | Oncol. Rep. | 2014 | 24317363 | miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1. |
| 32 | Feng et al. | Cancer | 2012 | 22139708 | MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. |
| 33 | Jurmeister et al. | Mol. Cell. Biol. | 2012 | 22144583 | MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. |
| 34 | Choi et al. | Mol. Cells | 2011 | 21544626 | Regulation of vascular endothelial growth factor signaling by miR-200b. |
| 35 | Chan et al. | Arterioscler. Thromb. Vasc. Biol. | 2012 | 22499991 | Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. |
| 36 | Tong et al. | Invest. Ophthalmol. Vis. Sci. | 2014 | 24667864 | TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3. |
| 37 | Xia et al. | Mol. Cell. Biochem. | 2010 | 20683643 | MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. |
| 38 | Fu et al. | J. Cell. Physiol. | 2014 | 24151081 | MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1. |
| 39 | Cai et al. | Graefes Arch. Clin. Exp. Ophthalmol. | 2012 | 22183793 | MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2. |
| 40 | Zhu et al. | Cancer Chemother. Pharmacol. | 2012 | 21993663 | miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. |
| 41 | Chen et al. | Cell Death Dis | 2013 | 23492772 | miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. |
| 42 | Peng et al. | Mol. Cell. Biochem. | 2013 | 23543137 | MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma. |
| 43 | Wang et al. | Oncotarget | 2015 | 25825983 | High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer. |
| 44 | Kwon et al. | Apoptosis | 2013 | 23546867 | Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1. |
| 45 | Helwak et al. | Cell | 2013 | 23622248 | Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. |
| 46 | Cesi et al. | Cell Cycle | 2011 | 22101269 | TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. |
| 47 | Cui et al. | Cell. Physiol. Biochem. | 2013 | 23735840 | SUZ12 depletion suppresses the proliferation of gastric cancer cells. |
| 48 | Peng et al. | Br. J. Cancer | 2013 | 24169343 | Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. |
| 49 | Tang et al. | Cancer Lett. | 2013 | 23851184 | Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22. |
| 50 | Tang et al. | Clin. Cancer Res. | 2013 | 23995857 | miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. |
| 51 | Li et al. | Oncogene | 2014 | 24037528 | MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. |
| 52 | Ning et al. | Cancer Lett. | 2015 | 25595591 | DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. |
| 53 | Pacurari et al. | Int. J. Oncol. | 2013 | 23708087 | The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. |
| 54 | Zhang et al. | Carcinogenesis | 2014 | 24064224 | miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. |
| 55 | Ye et al. | J Transl Med | 2014 | 24447584 | miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. |
| 56 | Liu et al. | Med. Oncol. | 2014 | 24477653 | miR-200b as a prognostic factor targets multiple members of RAB family in glioma. |
| 57 | Murray et al. | Invest. Ophthalmol. Vis. Sci. | 2013 | 23404117 | MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. |
| 58 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
| 59 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
| 60 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
| 61 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
| 62 | Gottwein et al. | Cell Host Microbe | 2011 | 22100165 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
| 63 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
| 64 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
| 65 | Cama et al. | Acta Neuropathol. | 2013 | 23955600 | Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling. |
| 66 | Li et al. | Carcinogenesis | 2013 | 23430952 | Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. |
| 67 | Yang et al. | J. Clin. Invest. | 2014 | 24762440 | ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. |
| 68 | Sun et al. | Oncogene | 2014 | 23975428 | RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. |
| 69 | Hart et al. | Mol. Cancer Res. | 2014 | 24337069 | Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing. |
| 70 | Zhang et al. | J. Biol. Chem. | 2013 | 24072701 | Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis. |
| 71 | Kim et al. | J. Biol. Chem. | 2013 | 24174534 | miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. |
| 72 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
| 73 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
| 74 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
| 75 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |